Scotiabank analyst Greg Harrison raised the firm’s price target on BridgeBio (BBIO) to $49 from $48 and keeps an Outperform rating on the ...
Palantir produced $2.8 billion in revenues in 2024, far and above BBAI’s $165 million. While that’s not a dealbreaker, ...
BNP Paribas, took a look at possible extreme scenarios investors should consider for 2025, like a 40% stock drop.
A €120 million provision in the bank’s accounts for UK motor finance risk is to recorded in the 2024 financial year as it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results